![Karin Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Walker
Comptroller/Controller/Auditor bei
PROTHENA CORPORATION PLC
Vermögen: 93 500 $ am 31.08.2026
Profil
Karin L.
Walker currently works at Prothena Corp.
Plc, as Chief Accounting Officer.
Ms. Walker also formerly worked at LifeSci Acquisition Corp., as Independent Directors in 2020, Cyclacel Pharmaceuticals, Inc., as Independent Non-Executive Director from 2020 to 2025, Affymax, Inc., as Chief Accounting Officer & Vice President-Finance from 2012 to 2013, Ernst & Young US LLP, as Accountant, CV Therapeutics, Inc., as Vice President-Finance & Controller from 2006 to 2009, and Amyris, Inc., as Vice President-Finance & Controller from 2009 to 2012.
Ms. Walker received her undergraduate degree from California Polytechnic State University (San Luis Obispo).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROTHENA CORP. PLC 0.02% | 28.07.2026 | 10’000 ( 0.02% ) | 93 500 $ | 31.08.2026 |
Aktive Positionen von Karin Walker
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 20.05.2013 |
Ehemalige bekannte Positionen von Karin Walker
| Unternehmen | Position | Ende |
|---|---|---|
| BIO GREEN MED SOLUTION, INC. | Direktor/Vorstandsmitglied | 03.01.2025 |
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 23.12.2020 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 01.05.2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 01.09.2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Comptroller/Controller/Auditor | 01.08.2009 |
Ausbildung von Karin Walker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Amyris, Inc.
 Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
